Background: Evolution of SARS-CoV-2 is continuous. Aim: Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity. Methods: In nasopharyngeal swabs of COVID-19 patients (n=1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined. Patients' demographic and clinical details were recorded. Associations between mild/moderate or severe COVID-19 and SARS-CoV-2 variants and patient characteristics were assessed by logistic regression. Rates and genomic locations of mutations, as well as quasi-species distribution (≥2 heterogeneous positions,≥50×coverage) were estimated based on 1,332 high-quality sequences. Results: Overall, 11 SARS-CoV-2 clades infected 1,762 study patients of median age 59years (interquartile range (IQR):45-73), with 52.5% (n=925) being male. In total, 101 non-synonymous substitutions/insertions correlated with disease prognosis (severe, n=27; mild-to-moderate, n=74). Several hotspots (mutation rates≥85%) occurred in Alpha, Delta, and Omicron variants of concern (VOCs) but none in pre-Alpha strains. Four hotspots were retained across all study variants, including spike:D614G. Average number of mutations per open-reading-frame (ORF) increased in the spike gene (average<5 per genome in January 2020 to>15 in 2022), but remained stable in ORF1ab, membrane, and nucleocapsid genes. Quasi-species were most prevalent in 20A/EU2 (48.9%), 20E/EU1 (48.6%), 20A (38.8%), and 21K/Omicron (36.1%) infections. Immunocompromised status and age (≥60years), while associated with severe COVID-19 or death irrespective of variant (odds ratio (OR):1.60-2.25; p≤0.014), did not affect quasi-species' prevalence (p>0.05). Conclusion: Specific mutations correlate with COVID-19 severity. Quasi-species potentially shaping VOCs' emergence are relevant to consider.

Berkell, M., Górska, A., Smet, M., Bachelet, D., Gentilotti, E., Guedes, M., et al. (2025). Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022. EUROSURVEILLANCE, 30(10), 1-18 [10.2807/1560-7917.ES.2025.30.10.2400038].

Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022

Caroccia, Natascia;Giannella, Maddalena;
2025

Abstract

Background: Evolution of SARS-CoV-2 is continuous. Aim: Between 01/2020 and 02/2022, we studied SARS-CoV-2 variant epidemiology, evolution and association with COVID-19 severity. Methods: In nasopharyngeal swabs of COVID-19 patients (n=1,762) from France, Italy, Spain, and the Netherlands, SARS-CoV-2 was investigated by reverse transcription-quantitative PCR and whole-genome sequencing, and the virus variant/lineage (NextStrain/Pangolin) was determined. Patients' demographic and clinical details were recorded. Associations between mild/moderate or severe COVID-19 and SARS-CoV-2 variants and patient characteristics were assessed by logistic regression. Rates and genomic locations of mutations, as well as quasi-species distribution (≥2 heterogeneous positions,≥50×coverage) were estimated based on 1,332 high-quality sequences. Results: Overall, 11 SARS-CoV-2 clades infected 1,762 study patients of median age 59years (interquartile range (IQR):45-73), with 52.5% (n=925) being male. In total, 101 non-synonymous substitutions/insertions correlated with disease prognosis (severe, n=27; mild-to-moderate, n=74). Several hotspots (mutation rates≥85%) occurred in Alpha, Delta, and Omicron variants of concern (VOCs) but none in pre-Alpha strains. Four hotspots were retained across all study variants, including spike:D614G. Average number of mutations per open-reading-frame (ORF) increased in the spike gene (average<5 per genome in January 2020 to>15 in 2022), but remained stable in ORF1ab, membrane, and nucleocapsid genes. Quasi-species were most prevalent in 20A/EU2 (48.9%), 20E/EU1 (48.6%), 20A (38.8%), and 21K/Omicron (36.1%) infections. Immunocompromised status and age (≥60years), while associated with severe COVID-19 or death irrespective of variant (odds ratio (OR):1.60-2.25; p≤0.014), did not affect quasi-species' prevalence (p>0.05). Conclusion: Specific mutations correlate with COVID-19 severity. Quasi-species potentially shaping VOCs' emergence are relevant to consider.
2025
Berkell, M., Górska, A., Smet, M., Bachelet, D., Gentilotti, E., Guedes, M., et al. (2025). Quasi-species prevalence and clinical impact of evolving SARS-CoV-2 lineages in European COVID-19 cohorts, January 2020 to February 2022. EUROSURVEILLANCE, 30(10), 1-18 [10.2807/1560-7917.ES.2025.30.10.2400038].
Berkell, Matilda; Górska, Anna; Smet, Mathias; Bachelet, Delphine; Gentilotti, Elisa; Guedes, Mariana; Franco-Yusti, Anna Maria; Mazzaferri, Fulvia; F...espandi
File in questo prodotto:
File Dimensione Formato  
eurosurv-30-10-4.pdf

accesso aperto

Tipo: Versione (PDF) editoriale / Version Of Record
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.79 MB
Formato Adobe PDF
1.79 MB Adobe PDF Visualizza/Apri
file supplementari (4).zip

accesso aperto

Tipo: File Supplementare
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione (CCBY)
Dimensione 1.07 MB
Formato Zip File
1.07 MB Zip File Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/1013158
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 1
  • ???jsp.display-item.citation.isi??? 1
social impact